Rituximab Maintenance After Autologous Transplantation

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2010
The goal of this clinical research is to see if Rituxan (rituximab) therapy given after high dose chemotherapy and transplant of a patients own stem cells will prevent or delay the return of the lymphoma.
Epistemonikos ID: e88da56b7179b1c4bb9577318da74e40b2fc8097
First added on: Nov 24, 2021